These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [The role of laparoscopy in the management of prostatic cancer]. Haas GP; Shumaker BP; Haas PA; Tóth C Orv Hetil; 1995 Sep; 136(37):2005-7. PubMed ID: 7566932 [TBL] [Abstract][Full Text] [Related]
29. [Prostatic cancer]. Shimazaki J Gan No Rinsho; 1989 Jan; Spec No():442-52. PubMed ID: 2644477 [No Abstract] [Full Text] [Related]
30. Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10. Bastian PJ; Gonzalgo ML; Aronson WJ; Terris MK; Kane CJ; Amling CL; Presti JC; Mangold LA; Humphreys E; Epstein JI; Partin AW; Freedland SJ Cancer; 2006 Sep; 107(6):1265-72. PubMed ID: 16900523 [TBL] [Abstract][Full Text] [Related]
31. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens. Cheng L; Poulos CK; Pan CX; Jones TD; Daggy JK; Eble JN; Koch MO J Urol; 2005 Sep; 174(3):898-902. PubMed ID: 16093983 [TBL] [Abstract][Full Text] [Related]
32. Pretreatment prostate-specific antigen and Gleason score predict the risk of extracapsular extension and the risk of failure following radiotherapy in patients with clinically localized prostate cancer. Roach M; Chen A; Song J; Diaz A; Presti J; Carroll P Semin Urol Oncol; 2000 May; 18(2):108-14. PubMed ID: 10875450 [TBL] [Abstract][Full Text] [Related]
33. Staging and reporting of prostate cancer--sampling of the radical prostatectomy specimen. Sakr WA; Wheeler TM; Blute M; Bodo M; Calle-Rodrigue R; Henson DE; Mostofi FK; Seiffert J; Wojno K; Zincke H Cancer; 1996 Jul; 78(2):366-8. PubMed ID: 8674019 [No Abstract] [Full Text] [Related]
34. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760 [TBL] [Abstract][Full Text] [Related]
36. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer. Sengupta S; Blute ML; Bagniewski SM; Inman B; Leibovich BC; Slezak JM; Myers RP; Zincke H BJU Int; 2008 Jan; 101(2):170-4. PubMed ID: 18173824 [TBL] [Abstract][Full Text] [Related]
37. [Prognostication of 5-year survival in patients after radical prostatectomy]. Al'-Shukri SKh; Borovets SIu Urologiia; 2005; (6):11-2. PubMed ID: 16419472 [No Abstract] [Full Text] [Related]
38. Surgical staging of carcinoma of the prostate. McCullough DL Cancer; 1980 Apr; 45(7 Suppl):1902-5. PubMed ID: 7370940 [No Abstract] [Full Text] [Related]
39. Oncologic outcome and patterns of recurrence after salvage radical prostatectomy. Paparel P; Cronin AM; Savage C; Scardino PT; Eastham JA Eur Urol; 2009 Feb; 55(2):404-10. PubMed ID: 18639970 [TBL] [Abstract][Full Text] [Related]
40. Editorial comment on: Prostate-specific antigen improves the ability of clinical stage and biopsy gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium. Stenman UH Eur Urol; 2007 Oct; 52(4):1074-5. PubMed ID: 17383813 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]